Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on: December 30,2023 10

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on:December 30,2023 10

Financial toxicity after robotic prostate cancer surgery: Younger patients at higher risk

byWolters Kluwer HealthPatient-reported outcomes measures changes during follow-up for groups (a-d). EF indicates erectile function domain; FT, financial toxicity; ICIQ-SF, International Consult

Updated on: December 25,2023 8

Financial toxicity after robotic prostate cancer surgery: Younger patients at higher risk

byWolters Kluwer HealthPatient-reported outcomes measures changes during follow-up for groups (a-d). EF indicates erectile function domain; FT, financial toxicity; ICIQ-SF, International Consult

Updated on:December 25,2023 8

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

byThe Spanish National Cancer Research CentreSection of a mouse invasive mesothelioma tumour. Credit: CNIOExposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggr

Updated on: December 22,2023 20

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

byThe Spanish National Cancer Research CentreSection of a mouse invasive mesothelioma tumour. Credit: CNIOExposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggr

Updated on:December 22,2023 20

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on: January 04,2024 9

Trial demonstrates one-year progression-free survival in 94% of patients with stage 3 or 4 classic Hodgkin lymphoma

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainA Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment wi

Updated on:January 04,2024 9

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on: August 12,2024 0

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on:August 12,2024 0

Chemotherapy could increase disease susceptibility in future generations

byWashington State UniversityCredit: Unsplash/CC0 Public DomainA common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, Washingto

Updated on: December 25,2023 8

Chemotherapy could increase disease susceptibility in future generations

byWashington State UniversityCredit: Unsplash/CC0 Public DomainA common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, Washingto

Updated on:December 25,2023 8

New compounds block master regulator of cancer growth, metastasis

by Diana Yates,University of Illinois at Urbana-ChampaignResearchers including, from left, graduate student Valeria Sanabria Guillen, research scientist Sung Hoon Kim, researcher Kathy Carlson,

Updated on: December 22,2023 16

New compounds block master regulator of cancer growth, metastasis

by Diana Yates,University of Illinois at Urbana-ChampaignResearchers including, from left, graduate student Valeria Sanabria Guillen, research scientist Sung Hoon Kim, researcher Kathy Carlson,

Updated on:December 22,2023 16

Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

by Franklin G. Berger,The ConversationCredit: American College of GastroenterologyA recently published study in a high-profile medical journal appeared to call into questionthe efficacy of

Updated on: December 26,2023 13

Colonoscopy is the most comprehensive screening for colorectal cancer, despite flawed interpretations of a new study

by Franklin G. Berger,The ConversationCredit: American College of GastroenterologyA recently published study in a high-profile medical journal appeared to call into questionthe efficacy of

Updated on:December 26,2023 13

Biomarker blood test confirms remission in patients with HPV+ oral cancer

byAmerican Society for Radiation OncologyA highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related

Updated on: December 18,2023 25

Biomarker blood test confirms remission in patients with HPV+ oral cancer

byAmerican Society for Radiation OncologyA highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related

Updated on:December 18,2023 25

Cancer patients who don't respond to immunotherapy may lack crucial immune cells

byWashington University School of MedicineCD5+ DC frequency was reduced in tumor-affected lymph nodes, and their presence correlated with greater patient survival in multiple tumors. CD5+D

Updated on: December 20,2023 12

Cancer patients who don't respond to immunotherapy may lack crucial immune cells

byWashington University School of MedicineCD5+ DC frequency was reduced in tumor-affected lymph nodes, and their presence correlated with greater patient survival in multiple tumors. CD5+D

Updated on:December 20,2023 12

Colonoscopy-screening does not prevent colorectal cancer as well as previously assumed

by Mathilde Coraline, Aarvold Bakke,University of OsloCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0On October 10 the world's first randomized study on usi

Updated on: December 26,2023 10

Colonoscopy-screening does not prevent colorectal cancer as well as previously assumed

by Mathilde Coraline, Aarvold Bakke,University of OsloCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0On October 10 the world's first randomized study on usi

Updated on:December 26,2023 10

Study shows lactate may prompt cancer formation

byCU Anschutz Medical CampusCancer cell during cell division. Credit: National Institutes of HealthA byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutate

Updated on: December 22,2023 19

Study shows lactate may prompt cancer formation

byCU Anschutz Medical CampusCancer cell during cell division. Credit: National Institutes of HealthA byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutate

Updated on:December 22,2023 19